PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $578,476 | -30.1% | 187,209 | +1.8% | 0.00% | – |
Q2 2023 | $827,141 | +230.6% | 183,809 | +318.8% | 0.00% | – |
Q1 2023 | $250,167 | -52.8% | 43,889 | -50.0% | 0.00% | – |
Q4 2022 | $530,180 | +82.8% | 87,778 | +100.0% | 0.00% | – |
Q3 2022 | $290,000 | +26.6% | 43,889 | 0.0% | 0.00% | – |
Q2 2022 | $229,000 | -84.2% | 43,889 | -79.1% | 0.00% | – |
Q1 2022 | $1,448,000 | -44.2% | 209,861 | +0.7% | 0.00% | – |
Q4 2021 | $2,595,000 | -90.2% | 208,406 | -75.5% | 0.00% | -100.0% |
Q3 2021 | $26,578,000 | -11.8% | 850,483 | -19.2% | 0.00% | -50.0% |
Q2 2021 | $30,125,000 | -20.4% | 1,052,216 | +20.5% | 0.00% | 0.0% |
Q1 2021 | $37,843,000 | +271.6% | 873,376 | +513.6% | 0.00% | +100.0% |
Q4 2020 | $10,184,000 | – | 142,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $66,362,000 | 1.23% |
Baker Brothers Advisors | 10,123,824 | $66,918,000 | 0.44% |
HHLR ADVISORS, LTD. | 583,333 | $3,856,000 | 0.10% |
CAXTON ASSOCIATES LP | 85,992 | $568,000 | 0.08% |
Virtus ETF Advisers LLC | 24,180 | $160,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 54,173 | $358,000 | 0.05% |
DENALI ADVISORS LLC | 8,200 | $54,000 | 0.03% |
PDT Partners, LLC | 12,641 | $84,000 | 0.01% |
UBS ASSET MANAGEMENT AMERICAS LLC | 2,402,595 | $15,881,153,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,949 | $244,000 | 0.01% |